Lenz Therapeutics Inc (LENZ)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2020 | 09-2020 | 06-2020 | 12-2019 | |
| Cash Flows From Operating Activities | ||||
| Net Income | -68,373 | -4,837 | -1,453 | -109 |
| Depreciation Amortization | 121 | 45 | 1 | 0 |
| Accounts payable and accrued liabilities | N/A | 393 | 280 | N/A |
| Other Working Capital | 1,709 | 1,645 | 454 | 10 |
| Other Operating Activity | 57,822 | -696 | -239 | 80 |
| Operating Cash Flow | $-8,721 | $-3,450 | $-957 | $-19 |
| Cash Flows From Investing Activities | ||||
| PPE Investments | -1,545 | -933 | -379 | 0 |
| Investing Cash Flow | $-1,545 | $-933 | $-379 | $0 |
| Cash Flows From Financing Activities | ||||
| Debt Issued | N/A | 5,000 | 5,000 | N/A |
| Common Stock Issued | N/A | 69 | N/A | N/A |
| Other Financing Activity | 30,077 | 9,887 | 9,998 | 0 |
| Financing Cash Flow | $30,077 | $14,956 | $14,998 | $0 |
| Beginning Cash Position | 6 | 6 | 6 | 25 |
| End Cash Position | 19,817 | 10,579 | 13,668 | 6 |
| Net Cash Flow | $19,811 | $10,573 | $13,662 | $-19 |
| Free Cash Flow | ||||
| Operating Cash Flow | -8,721 | -3,450 | -957 | -19 |
| Capital Expenditure | N/A | -933 | -379 | N/A |
| Free Cash Flow | -8,721 | -4,383 | -1,336 | -19 |